Capital DailyCapital Daily
Finance

Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares?

Hinge Health, a digital musculoskeletal care provider, reported a notable insider sale amid strong one-year share price gains.

Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares?

Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares?

Published June 12, 2026 · Category: Finance

Overview

Hinge Health‘s co-founder and executive chairman, Gabriel M.I. Mecklenburg, reported the sale of 50,000 Class A Common Stock shares for a transaction value of approximately $3.28 million, according to a SEC Form 4 filing.

Transaction value based on SEC Form 4 weighted average purchase price ($65.54); post-transaction value based on June 5, 2026, market close ($63.62).

Details

* 1-year price change calculated using June 12, 2026, as the reference date.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.